HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombophilia

A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
Also Known As:
Hypercoagulabilities; Thrombophilias; Hypercoagulability
Networked: 5406 relevant articles (122 outcomes, 570 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Inflammation (Inflammations)
2. Thrombosis (Thrombus)
3. Venous Thromboembolism
4. Venous Thrombosis (Deep-Vein Thrombosis)
5. Neoplasms (Cancer)

Experts

1. Glueck, Charles J: 44 articles (07/2020 - 06/2002)
2. Wang, Ping: 42 articles (07/2020 - 06/2002)
3. Rosendaal, F R: 35 articles (09/2015 - 01/2000)
4. Simioni, Paolo: 29 articles (08/2022 - 07/2003)
5. Nielsen, Vance G: 29 articles (04/2021 - 10/2002)
6. Martinelli, Ida: 28 articles (01/2021 - 05/2002)
7. Rosendaal, Frits R: 25 articles (05/2021 - 01/2002)
8. Brenner, Benjamin: 24 articles (11/2021 - 02/2002)
9. Middeldorp, Saskia: 21 articles (02/2022 - 01/2004)
10. De Stefano, Valerio: 21 articles (01/2021 - 05/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Thrombophilia:
1. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/01/2013 - "Retrospective case-control studies and recently published randomised controlled cohort studies have shown, that prophylactic administration of low-molecular-weight heparin (LWH), started in early pregnancy, may lead to a significant reduction in the incidence of PmC in subsequent pregnancies in patients with and without hereditary thrombophilias and previous PmC. "
03/01/2011 - "It remains a matter of debate if women with a previous history of (severe) P-EC should be screened for inherited thrombophilias and if the administration of low molecular weight heparin should be recommended in women with positive results to prevent adverse outcomes in subsequent pregnancies. "
10/01/2009 - "Preliminary nonrandomized studies suggest a benefit for prophylaxis with unfractioned and low-molecular-weight heparin (LMWH), and prospective randomized trials are in progress to define whether LMWH is effective in preventive pregnancy loss and other gestational vascular complications in women with thrombophilia and previus fetal wastage."
06/01/2003 - "Preliminary non-randomized studies suggest a benefit for prophylaxis with unfractionated and low-molecular-weight heparin (LMWH), and prospective randomized trials are in progress to define whether LMWH is effective in preventing pregnancy loss and other gestational vascular complications in women with thrombophilia and previous fetal wastage."
11/25/2002 - "Preliminary case-control studies suggest a benefit for prophylaxis with low molecular weight heparins (LMWH), and prospective randomized trials are in progress to define whether LMWH are effective in preventing pregnancy loss in women with thrombophilia and previous fetal wastage."
2. AnticoagulantsIBA
3. Heparin (Liquaemin)FDA LinkGeneric
4. Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
5. Biomarkers (Surrogate Marker)IBA
6. DabigatranFDA Link
7. factor V LeidenIBA
8. Hemostatics (Antihemorrhagics)IBA
9. Enoxaparin (Lovenox)FDA LinkGeneric
10. Warfarin (Coumadin)FDA LinkGeneric

Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)
3. Drug Therapy (Chemotherapy)
4. Hormone Replacement Therapy (Therapy, Hormone Replacement)
5. Free Tissue Flaps